ArticleEffect of High Flux Hemodialysis versus Hemodiafiltration on Metabolic Status in Hemodialysis Patients
ArticleEffect of High Flux Hemodialysis versus Hemodiafiltration on Metabolic Status in Hemodialysis Patients
ArticleEffects of High Flux versus Low Flux on Serum C-Reactive Protein A as an Inflammatory Biomarker in Hemodialysis Patients
ArticleEffects of High Flux versus Low Flux on Serum C-Reactive Protein A as an Inflammatory Biomarker in Hemodialysis Patients
ArticleHigh Flux Versus Low Flux Dialysis: Impact on Intradialytic Hypertension and Adequacy of Dialysis
ArticleHigh Flux Versus Low Flux Dialysis: Impact on Intradialytic Hypertension and Adequacy of Dialysis
ArticleFibroblast growth factor-23 is independently associated with the left ventricular mass index in hemodialysis patients
ArticleFibroblast growth factor-23 is independently associated with the left ventricular mass index in hemodialysis patients
ArticleEffect of Blood and Fistula Flow Rates on Dialysis Adequacy, Phosphate Removal and Cardiac Function in Hemodialysis Patients
ArticleEffect of Blood and Fistula Flow Rates on Dialysis Adequacy, Phosphate Removal and Cardiac Function in Hemodialysis Patients
ArticleEffect of high volume hemodiafiltration on secondary hyperparathyroidism among hemodialysis patients
ArticleEffect of high volume hemodiafiltration on secondary hyperparathyroidism among hemodialysis patients
ArticleSerum Level of Fibroblast Growth Factor 23 in Patients with Uremic Pruritus Undergoing Hemodialysis
ArticleSerum Level of Fibroblast Growth Factor 23 in Patients with Uremic Pruritus Undergoing Hemodialysis
ArticleEffect of High Flux Versus Low Flux Hemodialysis on Some Cardiovascular Risk Factors in Egyptian Children with End Stage Renal Disease.
ArticleEffect of High Flux Versus Low Flux Hemodialysis on Some Cardiovascular Risk Factors in Egyptian Children with End Stage Renal Disease.
ArticleSTUDY OF SERUM FIBROBLAST GROWTH FACTOR 23 IN RELATION TO DIASTOLIC DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS
ArticleSTUDY OF SERUM FIBROBLAST GROWTH FACTOR 23 IN RELATION TO DIASTOLIC DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS